Skip to Content
Merck
CN

PROTIA

ProteoPrep® Immunoaffinity Albumin & IgG Depletion Kit

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

NACRES:
NA.56
UNSPSC Code:
41106500

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

technique(s)

immunodepletion: suitable

storage temp.

2-8°C

Quality Level

200

Related Categories

Application

ProteoPrep® Immunoaffinity Albumin & amp; IgG Depletion Kit has been used in:
  • umbilical cord serum proteomics
  • human plasma (HP) proteomics
  • proteomic profile-based screening of potential protein biomarkers in the urine of patients with nephrotic syndrome

Disclaimer

For U.S. Customers: Contains mercury; Do not place in trash - dispose according to local, state, or federal laws.

Features and Benefits

  • High Capacity removes more interfering abundant proteins
  • High Specifity ensures you see an accurate and more complete proteome
  • Buffer systems are compatible with 2 dimensional electrophoresis so there are no intermediate time consuming steps that might result in protein loss

General description

ProteoPrep® Immunoaffinity Albumin and IgG Depletion Kit might be a useful tool for novel biomarker discovery.
The ProteoPrep® Immunoaffinity medium in the prepacked spin columns is a mixture of two-beaded media containing recombinantly expressed, small single-chain antibody ligands, resulting in low non-specific binding and high capacity. The ProteoPrep Immunoaffinity Albumin and IgG Depletion Kit has been designed to specifically remove albumin and IgG from human serum (25-50μL) in preparation of samples for proteomics analysis, two-dimensional electrophoresis (2DE) or liquid chromatography (LC). This kit is also effective in depleting albumin and IgG from mouse and guinea pig serum.

Legal Information

ProteoPrep is a registered trademark of Merck KGaA, Darmstadt, Germany

signalword

Warning

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Chronic 2 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - Skin Sens. 1

Storage Class

10 - Combustible liquids

Regulatory Information

低风险生物材料
常规特殊物品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000437776
0000437776
SLCL4825
SLCL3124
SLCH8965

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

  1. Which document(s) contains shelf-life or expiration date information for a given product?

    If available for a given product, the recommended re-test date or the expiration date can be found on the Certificate of Analysis.

  2. How do I get lot-specific information or a Certificate of Analysis?

    The lot specific COA document can be found by entering the lot number above under the "Documents" section.

  3. My protein samples contain urea.  Can I still use the ProteoPrep® Immunoaffinity Albumin & IgG Depletion Kit, Product PROTIA, for depletion?

    The presence of urea can reduce the depletion of albumin with PROTIA.  We would suggest a buffer exchange prior to depletion using either dialysis or 5 KDa NMWL cut-off spin filters.

  4. Can I use the ProteoPrep® Immunoaffinity Albumin & IgG Depletion Kit, Product PROTIA, on samples besides serum?

    Besides human serum or plasma samples, we have not specifically tested other human biological fluids with this kit.  However, in principle, there is no reason not to try the kit with other fluid samples.

  5. How do I find price and availability?

    There are several ways to find pricing and availability for our products. Once you log onto our website, you will find the price and availability displayed on the product detail page. You can contact any of our Customer Sales and Service offices to receive a quote.  USA customers:  1-800-325-3010 or view local office numbers.

  6. What is the Department of Transportation shipping information for this product?

    Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product. 

  7. My question is not addressed here, how can I contact Technical Service for assistance?

    Ask a Scientist here.

Federica Re et al.
Journal of tissue engineering, 10, 2041731419845852-2041731419845852 (2019-05-21)
Bone marrow and adipose tissue human mesenchymal stem cells were seeded in highly performing 3D gelatin-chitosan hybrid hydrogels of varying chitosan content in the presence of human platelet lysate and evaluated for their proliferation and osteogenic differentiation. Both bone marrow
Elena Guillén-Gómez et al.
Journal of diabetes research, 2018, 6165303-6165303 (2018-06-02)
Urinary proteome was analyzed and quantified by tandem mass tag (TMT) labeling followed by bioinformatics analysis to study diabetic nephropathy (DN) pathophysiology and to identify biomarkers of a clinical outcome. We included type 2 diabetic normotensive non-obese males with (n
Carmen R M Bria et al.
Analytical and bioanalytical chemistry, 411(3), 777-786 (2018-11-25)
High- and low-density lipoproteins (HDL and LDL) are attractive targets for biomarker discovery. However, ultracentrifugation (UC), the current methodology of choice for isolating HDL and LDL, is tedious, requires large sample volume, results in sample loss, and does not readily
Yu Wang et al.
Molecular medicine reports, 16(5), 6276-6284 (2017-08-30)
Nephrotic syndrome is not a single disease; rather, it is a term for numerous diseases and pathological types. Renal biopsy is of use in determining the diagnosis and prognosis, and for guiding treatment; however, the use of this intervention is
Christophe Schmitt et al.
Journal of cardiovascular pharmacology, 65(6), 611-619 (2015-02-26)
Inclacumab, a novel monoclonal antibody against P-selectin in development for the treatment and prevention of atherosclerotic cardiovascular diseases, was administered in an ascending single-dose study as intravenous infusion to evaluate safety, pharmacokinetics, and pharmacodynamics. Fifty-six healthy subjects were enrolled in
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service